The German multinational pharma and biotech colossus Bayer is taking further steps to ramp up its focus on digital health by launching a new business unit. In 2022, Bayer invested $9.5 million in Woebot Health, an AI-powered behavioral health platform company. In 2020, it launched a venture known as G4A Digital Health Partnership Program to…
Emory and Pfizer partner to develop new COVID-19 treatments
Emory University has partnered with Pfizer (NYSE:PFE) to create new drugs and therapies aimed at stopping serious disease from COVID-19. The Emory and Pfizer collaboration will take place in Emory University’s Schinazi Laboratory, led by scientist Raymond Schinazi, with the goal of producing novel antiviral compounds to combat COVID, according to The Atlanta Journal-Constitution. Although…
The data to solve many pharmaceutical research problems already exists. We just need to harness it.
In searching for new therapies, pharmaceutical research teams worldwide are conducting experiments daily and generating knowledge. Thanks to this constantly expanding pool of scientific data, we are starting projects with access to more information than ever before. Data is good. The right data is better. But finding the right data is no easy task. Inaccessible…